Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02363959 · ClinicalTrials.gov registry record · Phase 2
Hyperbaric Oxygen Therapy for Lung Transplantation
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT02363959 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 20 participants.
The verdict
NCT02363959, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on airway complications in post-lung transplant recipients with evidence of restricted levels of blood and oxygen in the airway tissue. Study subjects with extensive airway tissue damage in the early post-transplant period will be randomized to HBOT or usual care and followed clinically for 12 months following randomization. The investigators hypothesize that HBOT will decrease the number of airway complications in the treated subjects.
Interventions
- DRUG Hyperbaric Oxygen Therapy
- PROCEDURE Endobronchial Biopsy of Airway Epithelium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-02 |
| Est. Completion | 2018-09-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02363959
The ClinicalTrials.gov registry entry for NCT02363959 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hyperbaric Oxygen Therapy is the first listed.
NCT02363959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02363959 about?
NCT02363959 is a clinical study titled "Hyperbaric Oxygen Therapy for Lung Transplantation". The objective of this study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on airway complications in post-lung transplant recipients with evidence of restricted levels of blood and oxygen in the airway tissue. Study subjects with extensive airway tissue damage in the early post-trans...
What is the current status of trial NCT02363959?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2015-02. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02363959?
The interventions under investigation include: Hyperbaric Oxygen Therapy (DRUG), Endobronchial Biopsy of Airway Epithelium (PROCEDURE).
Who is sponsoring clinical trial NCT02363959?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.